Skip to content

Consensus Guidelines for Pre- and Post-Procedure Skincare in Aesthetic Treatments

Consensus Guidelines for Pre- and Post-Procedure Skincare in Aesthetic Treatments

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07334353
Enrollment
15
Registered
2026-01-12
Start date
2026-05-01
Completion date
2027-02-01
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre and Post Procedure Skin Care, Skin Care

Keywords

Aesthetics, Aesthetic procedures, Skin care

Brief summary

This consensus protocol outlines standardized pre- and post-procedure skincare practices designed to optimize treatment outcomes, enhance skin recovery, and minimize complications following aesthetic procedures. It provides evidence-based guidance for skin preparation before treatment and structured aftercare to support healing, reduce inflammation, prevent infection, and maintain long-term results.

Detailed description

This protocol presents a Delphi-based expert consensus on standardized pre- and post-procedure skincare for aesthetic treatments, developed to optimize clinical outcomes, enhance patient safety, and minimize procedure-related complications. The recommendations apply to a broad spectrum of aesthetic interventions, including injectables, laser and energy-based devices, chemical peels, microneedling, and combination therapies. Consensus Development Methodology (Delphi Method) This protocol is developed using the Delphi method, a structured, iterative process designed to achieve expert agreement through multiple rounds of anonymous feedback. A multidisciplinary panel of experienced aesthetic physicians, dermatologists, and skincare experts participates in sequential survey rounds. Each round refines key recommendations based on: * Aggregated expert responses * Controlled feedback * Statistical agreement thresholds This approach ensures that the final protocol reflects high-level expert agreement, minimizes bias, and supports evidence-informed clinical decision-making.

Interventions

None listed

Sponsors

Venus Research Center
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Licensed dermatologists, plastic surgeons, and aesthetic medicine specialists. * Minimum of five years of clinical experience in aesthetic procedures, including lasers, injectables, chemical peels, or microneedling. * Demonstrated record of academic or clinical involvement in procedural dermatology or aesthetic medicine. * Experience managing patients across a range of skin phototypes, particularly Fitzpatrick III-VI. * Willingness to participate in multiple rounds of survey-based consensus building. * Commitment to provide independent and anonymous responses

Exclusion criteria

* Lack of direct clinical experience with aesthetic procedures. * Less than five years of relevant clinical practice. * Inability to commit to all rounds of the Delphi process. * Conflicts of interest that could bias recommendations (e.g., financial ties to skincare product companies or device manufacturers). * Insufficient proficiency in the language used for the Delphi survey. * Failure to complete the initial round, resulting in removal from subsequent rounds.

Design outcomes

Primary

MeasureTime frameDescription
Level of Expert Consensus on Pre- and Post-Procedure Skincare Protocols for Aesthetic Procedures6-8 weeksThe primary outcomes of this Delphi study are the levels of expert consensus on recommended pre- and post-procedure skincare protocols across various aesthetic procedures. Specifically, the study aims to determine expert agreement on: (1) pre-procedure skin preparation measures, including barrier optimization, hydration, photoprotection, and any topical priming agents; (2) post-procedure care, including barrier repair, management of erythema or inflammation, photoprotection, and timing for reintroduction of active topical agents

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026